Leerink Partners has published 36 price target changes across 20 S&P 500 large caps in our dataset. Of the revisions that moved a target up or down, 42% were increases.
Most recent revision: Sep 18, 2026
| Date | Ticker | Action | Target | Change |
|---|---|---|---|---|
| Sep 18, 2026 | HCA HCA Healthcare, Inc. | Maintains | $492→$492 | 0.0% |
| Sep 9, 2026 | MRK Merck & Company, Inc. | Raises | $127→$161 | +26.8% |
| Aug 17, 2026 | REGN Regeneron Pharmaceuticals, Inc. | Raises | $641→$824 | +28.5% |
| Jul 21, 2026 | GILD Gilead Sciences, Inc. | Lowers | $146→$127 | -13.0% |
| Jul 17, 2026 | ELV Elevance Health, Inc. | Raises | $364→$395 | +8.5% |
| Jul 17, 2026 | ISRG Intuitive Surgical, Inc. | Lowers | $573→$454 | -20.8% |
| Jun 25, 2026 | LLY Eli Lilly and Company | Raises | $1119→$1232 | +10.1% |
| Jun 17, 2026 | UNH UnitedHealth Group Incorporated | Raises | $400→$462 | +15.5% |
| Jun 5, 2026 | SYK Stryker Corporation | Lowers | $410→$407 | -0.7% |
| Jun 4, 2026 | MDT Medtronic plc. | Lowers | $117→$104 | -11.1% |
| May 28, 2026 | BSX Boston Scientific Corporation | Lowers | $87→$74 | -14.9% |
| May 18, 2026 | REGN Regeneron Pharmaceuticals, Inc. | Lowers | $792→$641 | -19.1% |
| May 13, 2026 | JNJ Johnson & Johnson | Announces | $0→$265 | - |
| Apr 22, 2026 | UNH UnitedHealth Group Incorporated | Raises | $345→$400 | +15.9% |
| Apr 22, 2026 | ISRG Intuitive Surgical, Inc. | Lowers | $622→$573 | -7.9% |
| Apr 13, 2026 | SYK Stryker Corporation | Announces | $0→$410 | - |
| Feb 4, 2026 | AMGN Amgen Inc. | Raises | $305→$355 | +16.4% |
| Jan 28, 2026 | UNH UnitedHealth Group Incorporated | Lowers | $410→$345 | -15.9% |
| Dec 29, 2025 | VRTX Vertex Pharmaceuticals Incorpor | Raises | $456→$525 | +15.1% |
| Nov 27, 2025 | AMGN Amgen Inc. | Lowers | $352→$305 | -13.4% |
| Nov 10, 2025 | LLY Eli Lilly and Company | Raises | $886→$1104 | +24.6% |
| Oct 22, 2025 | TMO Thermo Fisher Scientific Inc | Raises | $545→$580 | +6.4% |
| Sep 25, 2025 | VRTX Vertex Pharmaceuticals Incorpor | Lowers | $458→$456 | -0.4% |
| Sep 24, 2025 | MCK McKesson Corporation | Raises | $785→$850 | +8.3% |
| Jul 18, 2025 | ELV Elevance Health, Inc. | Lowers | $510→$310 | -39.2% |
| Jul 17, 2025 | ZTS Zoetis Inc. | Lowers | $180→$155 | -13.9% |
| Jun 16, 2025 | MDT Medtronic plc. | Announces | $0→$110 | - |
| May 13, 2025 | JNJ Johnson & Johnson | Lowers | $169→$153 | -9.5% |
| May 6, 2025 | VRTX Vertex Pharmaceuticals Incorpor | Lowers | $550→$503 | -8.5% |
| Feb 13, 2025 | CVS CVS Health Corporation | Raises | $55→$75 | +36.4% |
| Jan 13, 2025 | MRK Merck & Company, Inc. | Lowers | $136→$119 | -12.5% |
| Dec 2, 2024 | ZTS Zoetis Inc. | Announces | $0→$215 | - |
| Nov 19, 2024 | IQV IQVIA Holdings, Inc. | Lowers | $260→$248 | -4.6% |
| Oct 7, 2024 | MCK McKesson Corporation | Lowers | $665→$630 | -5.3% |
| Sep 5, 2024 | MCK McKesson Corporation | Lowers | $670→$665 | -0.7% |
| Jul 24, 2024 | DHR Danaher Corporation | Raises | $275→$280 | +1.8% |
Names Leerink Partners has revised most often, shown with its latest target and the implied move from the current share price.
A. Our dataset contains 36 price target changes published by Leerink Partners across 20 S&P 500 large caps. Of the moves that raised or lowered a target, 42% were increases. The most recent entry is dated Sep 18, 2026.
A. Leerink Partners has issued 22 target changes in the last 12 months within our watchlist. The table above lists the 36 most recent, including the prior and revised target for each name.
A. A single firm's target is one opinion. The stock pages on Analyst Signal show the consensus mean target across all covering analysts, which is usually a more stable reference point than any individual revision.
Data provided by Yahoo Finance. This information is for informational purposes only and does not constitute investment advice. We bear no legal responsibility for any investment decisions made based on this data.